Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1224 Results

Title
Intervention Indication Therapeutic Area Year Actions
Relugolix combination therapy for treating endometriosis-associated pain Relugolix (TAK-385) Endometriosis-associated pain Gynaecology and Obstetrics , Pain Relief 2021 View  |  Download
Relugolix for treating advanced hormone-sensitive prostate cancer Relugolix (TAK-385) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
Relugolix in combination with estradiol/norethindrone acetate for moderate to severe symtpoms of uterine fibroids Relugolix (TAK-385) Heavy menstrual bleeding Gynaecology and Obstetrics 2020 View  |  Download
Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines Remibrutini (LOU064) Chronic spontaneous urticaria (CSU) Dermatology 2023 View  |  Download
Remimazolam for general anaesthesia – first line Remimazolam (CNS 7056; ONO-2745) Anaesthesia Neurology 2020 View  |  Download
Remimazolam for procedural sedation Remimazolam (CNS 7056; ONO-2745) Procedural sedation Neurology 2020 View  |  Download
Repotrectinib for treating advanced or metastatic nonsmall-cell lung cancer with ROS1-postive mutation Repotrectinib (TPX 0005) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Resmetirom for non-alcoholic steatohepatitis Resmetirom (MGL-3196) Non-alcoholic steatohepatitis (NASH) Hepatology 2023 View  |  Download
Resminostat for maintenance treatment of patients with advanced stage mycosis fungoides or Sézary syndrome Resminostat (4SC-201) Cutaneous T-cell lymphoma (CTCL) , Mycosis fungoides or sezary syndrome Haematological Cancer and Lymphomas , Skin Cancer 2024 View  |  Download
Retifanlimab for advanced/metastatic merkel cell carcinoma Retifanlimab (INCMGA00012; MGA-012) Merkel cell carcinoma (MCC) Skin Cancer 2021 View  |  Download
1 2 90 91 92 93 94 122 123
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications